Skip to content

Interpretable QSAR modelling for PPAR-γ agonist prediction by integrating a stacking strategy, docking, and MD simulations.

Aug 2026 · Molecular diversity · 0 citations · 76 references
Medicine

TL;DR

Meta-iPPAR is developed, an integrative in silico framework combining stacked machine learning, molecular docking, and molecular dynamics simulations for the identification of PPAR-γ agonists that will be an effective computational tool for screening and prioritizing potential compounds targeting PPAR-γ in the early stage of drug development pipelines.

View source

Similar papers

Open access Jul 2026

Identification of phillyrin as a PPAR-γ ligand through network pharmacology and molecular modeling.

This work adopted a combined in silico and experimental approach to determine whether phillyrin could function as a ligand of PPAR-γ, and implemented a multi-scale strategy integrating network pharmacology, molecular modeling, with experimental verification.

Ling Huang, Zhizheng Fang, Rongchun Han et al. · 0 citations
Review Open access Jul 2026

Integrated CADD, Molecular Docking and ADMET Prediction in Anti-Inflammatory Lead Discovery: A Review

The article emphasizes that docking scores are hypothesis-generating outputs and must be interpreted with binding-pose quality, residue relevance, pharmacokinetic feasibility and safety prediction.

Vikas M. Mohanale, Dr. Ravi U. Kurhade, Dr. Manoj H. Dev, Amol S. Dhakpade, Nishinandan M. Shinde · 0 citations
Review Jul 2026

GRAPH NEURAL NETWORK-GUIDED VIRTUAL SCREENING AND CORE-HOPPING-BASED DESIGN OF NOVEL PPAR-γ MODULATORS

An integrated GNN-guided virtual screening and core-hopping workflow tailored specifically to PPAR-γ modulator design is proposed, built around the goal of identifying selective partial agonists and biased ligands that retain insulin-sensitizing efficacy while minimizing helix-12-driven adverse transcriptional programs...

Deepansha Gandhi, Megha Mishra, Kalyani Bokde et al. · 0 citations
Jul 2026

Modeling Structure-Activity Relationships with Machine Learning to Identify DPP4 Inhibitors as potential Therapeutics for Type 2 Diabetes

Findings identify CP20 as a promising lead scaffold for the development of novel DPP4 inhibitors and demonstrate the effectiveness of an ensemble machine learning-guided computational framework for accelerating antidiabetic drug discovery.

Iqra Anwar, T. Chohan, Drakhshaan et al. · 0 citations
Open access Aug 2026

A Comprehensive Study Utilizing QSAR, Virtual Screening, Molecular Docking, Molecular Dynamics, and MM/GBSA Analyses Reveals Natural Diterpenoids as Promising Caspase-1 Inhibitors

This study highlights natural diterpenoids and coumarin glycosides as promising scaffolds for caspase-1 inhibition and demonstrates that integrating QSAR modeling with structure-based approaches provides an efficient strategy for discovering potential anti-inflammatory drug candidates.

Yusuf Şeflekçi, Alper Yılmaz, Abdulilah Ece · 0 citations
Open access Jul 2026

An integrative computational strategy for antidiabetic drug discovery: From QSAR modeling to retrosynthesis

A comprehensive computational approach was used to identify novel ligands with potent inhibitory activity against various indenoquinoxaline-phenylacrylohydrazide hybrids, highlighting a promising lead compound for further in vitro and in vivo investigations targeting α-amylase inhibition.

L. Naanaai, M. Alaqarbeh, A. El Aissouq et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.